WallStreetZenWallStreetZen

NASDAQ: ASLN
Aslan Pharmaceuticals Ltd Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

ASLN past revenue growth

How has ASLN's revenue growth performed historically?
Company
N/A
Industry
151.46%
Market
17.61%
ASLN's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ASLN's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance

ASLN earnings and revenue history

Current Revenue
$12.0M
Current Earnings
-$44.2M
Current Profit Margin
-368.5%

ASLN Return on Equity

Current Company
-8,453.6%
Current Industry
-63.5%
Current Market
188%
ASLN's Return on Equity (-8,453.6%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ASLN announces earnings.

ASLN Return on Assets

Current Company
-95.7%
Current Industry
2.9%
ASLN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ASLN Return on Capital Employed

Current Company
-345.35%
Current Industry
19.5%
ASLN's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ASLN vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ASLN$12.00M-$39.41M-$44.22M+41.42%N/A
AEZS$4.50M-$16.38M-$16.55M-30.06%N/A
BRTX$145.80k-$14.16M-$14.42M+5.61%N/A
PBM$0.00$1.52M$1.52MN/AN/A
PPBT$0.00$22.27M$19.88M-100.00%N/A
View Top Biotech Stocks

ASLN earnings dates

Next earnings date
Apr 26, 2024

Aslan Pharmaceuticals Earnings & Revenue FAQ

What were ASLN's earnings last quarter?

On Invalid Date, Aslan Pharmaceuticals (NASDAQ: ASLN) reported Q4 2023 earnings per share (EPS) of -$0.75, up 25% year over year. Total Aslan Pharmaceuticals earnings for the quarter were -$13.51 million. In the same quarter last year, Aslan Pharmaceuticals's earnings per share (EPS) was -$1.00.

If you're new to stock investing, here's how to buy Aslan Pharmaceuticals stock.

What was ASLN's earnings growth in the past year?

As of Q2 2024, Aslan Pharmaceuticals's earnings has grown year over year. Aslan Pharmaceuticals's earnings in the past year totalled -$44.22 million.

What is ASLN's earnings date?

Aslan Pharmaceuticals's earnings date is Invalid Date. Add ASLN to your watchlist to be reminded of ASLN's next earnings announcement.

What was ASLN's revenue last quarter?

On Invalid Date, Aslan Pharmaceuticals (NASDAQ: ASLN) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Aslan Pharmaceuticals's revenue was $0.00.

What was ASLN's revenue growth in the past year?

As of Q2 2024, Aslan Pharmaceuticals's revenue has grown null year over year. Aslan Pharmaceuticals's revenue in the past year totalled $12.00 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.